GRIFOLS | GRF - Cost Of Sales

Stock Price
8.88
Daily Change
-0.56 -5.93%
Monthly
-8.74%
Yearly
12.69%
Q2 Forecast
8.94

GRIFOLS reported EUR1.29B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Alcon AG USD 1.2B 46M Dec/2025
Almirall EUR 191.5M 2.29M Dec/2025
Amadeus IT EUR 641.1M 260.4M Dec/2025
Amarin USD 26.05M 1.41M Dec/2025
argenx SE USD 149.69M 40.26M Dec/2025
AstraZeneca USD 3.27B 471M Dec/2025
Bayer EUR 4.5B 194M Dec/2025
Cie Automotive EUR 1.21B 19.7M Dec/2025
Demant DKK 2.89B 188M Dec/2025
Ence Energia y Celulosa EUR 109.33M 21.97M Dec/2025
Essilor EUR 6.06B 741M Dec/2025
Ferrovial EUR 867M 120M Dec/2025
Fresenius EUR 4.45B 262M Dec/2025
Fresenius Medical Care EUR 3.68B 38.37M Dec/2025
Galapagos EUR 455K 84.28M Dec/2025
Genmab DKK 81M 23M Dec/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
GRIFOLS EUR 1.29B 163.12M Dec/2025
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Inditex EUR 6.19B 1.67B Dec/2025
Merck EUR 2.29B 183M Dec/2025
Novartis USD 3.54B 3M Dec/2025
Philips EUR 2.81B 417M Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 4.29B 421M Dec/2025
Smith & Nephew USD 870M 17M Dec/2025
UCB EUR 1.07B 146M Dec/2025
Viscofan EUR 202.61M 1.65M Dec/2025